Amoxicillin Dosing for H. pylori Eradication
For H. pylori treatment, use amoxicillin 1 gram twice daily (every 12 hours) in standard triple therapy regimens, or 1 gram three times daily (every 8 hours) in dual therapy regimens, both for 14 days. 1
Standard Dosing Regimens
The FDA-approved dosing for H. pylori eradication provides two options 1:
Triple Therapy (Preferred)
- Amoxicillin 1 gram twice daily (every 12 hours)
- Clarithromycin 500 mg twice daily
- PPI (lansoprazole 30 mg or equivalent) twice daily
- Duration: 14 days
Dual Therapy (Alternative)
- Amoxicillin 1 gram three times daily (every 8 hours)
- PPI (lansoprazole 30 mg or equivalent) three times daily
- Duration: 14 days
Guideline-Based Recommendations
The 2021 AGA guidelines 2 specify amoxicillin dosing across multiple regimens:
- Concomitant therapy: Amoxicillin 1g bid
- Clarithromycin triple therapy: Amoxicillin 1g bid
- Levofloxacin triple therapy: Amoxicillin 1g bid
- Rifabutin triple therapy: Amoxicillin 1g bid
- High-dose dual therapy: Amoxicillin 2-3g daily in 3-4 split doses
Critical Dosing Considerations
Frequency Matters More Than Total Daily Dose
Amoxicillin should be dosed at least three times daily when possible, as this significantly improves eradication rates. Research demonstrates that tid or qid dosing achieves 90-95% eradication compared to only 78-81% with bid dosing 3. This is because amoxicillin's bactericidal effect depends on time above minimum inhibitory concentration (%time-above-MIC), not peak concentration.
High-Dose Dual Therapy
For areas with high clarithromycin resistance, high-dose amoxicillin (2-3 grams daily in 3-4 divided doses) combined with high-dose PPI or PCAB achieves 85-90% eradication rates 2, 4. The most effective regimen uses high-dose amoxicillin with PCAB and bismuth, achieving >95% eradication 4.
Weight-Based Dosing in Obesity
In patients with obesity (particularly bariatric surgery candidates), consider weight-adjusted dosing at 50 mg/kg/day based on adjusted body weight, not exceeding 6 grams daily. This approach increases eradication rates from 68% to 90% in this population 5. Standard fixed doses may result in subtherapeutic mucosal concentrations due to increased volume of distribution.
Administration Guidelines
- Take at the start of meals to minimize gastrointestinal intolerance 1
- Dose 30 minutes before eating when using with PPI for optimal acid suppression 2
- Continue for minimum 14 days (not 7 days, which is outdated)
Renal Impairment Adjustments
For patients with severe renal impairment 1:
- GFR 10-30 mL/min: 500 mg every 12 hours
- GFR <10 mL/min: 500 mg every 24 hours
- Hemodialysis: 500 mg every 24 hours, with additional dose during and after dialysis
Common Pitfalls to Avoid
- Don't use twice-daily dosing when three or four times daily is feasible - this is the single most modifiable factor affecting eradication success
- Don't use 7-day regimens - 14 days is now standard 2, 1
- Don't use fixed doses in patients with obesity - consider weight-based dosing 5
- Don't prescribe the 875 mg tablet formulation for H. pylori - this dose is not validated for this indication
Regional Resistance Considerations
The 2022 AGA stewardship primer 6 emphasizes that amoxicillin is classified in the WHO "Access group" with low resistance potential (<3% worldwide resistance). This makes it preferable to clarithromycin and levofloxacin ("Watch group" antibiotics) for first-line therapy, particularly in mass eradication programs.
When local clarithromycin resistance exceeds 15%, bismuth quadruple therapy or high-dose amoxicillin dual therapy should replace clarithromycin-based triple therapy as first-line treatment 2, 6.